Industry Research Reports

Home > Reports > Pharma & Healthcare > Epoetin (Eritropoyetin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Epoetin (Eritropoyetin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 132 Pages

Report ld: 2341336

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Epoetin can be given intravenously or, more conveniently, subcutaneously, when a 25–50% lower dose can be used.

The global market for Epoetin (Eritropoyetin) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Epoetin (Eritropoyetin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Epoetin (Eritropoyetin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Epoetin (Eritropoyetin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Epoetin (Eritropoyetin) include Amgen, Epoetin, Abcam, Johnson & Johnson, Hospira Inc, Roche, LG Life Sciences Ltd, Biocon and Intas Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Epoetin (Eritropoyetin), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Epoetin (Eritropoyetin) by region & country, by Type, and by Application.

The Epoetin (Eritropoyetin) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epoetin (Eritropoyetin).

Market Segmentation

Report Metric
Details
Report Title
Epoetin (Eritropoyetin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Epoetin (Eritropoyetin) Companies Covered
Amgen, Epoetin, Abcam, Johnson & Johnson, Hospira Inc, Roche, LG Life Sciences Ltd, Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd, Ranbaxy Laboratories Ltd, Celltrion, Inc
Global Epoetin (Eritropoyetin) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epoetin (Eritropoyetin) Market, Segment by Type
Epoetin-alfa

Epoetin-beta

Darbepoetin Alfa
Global Epoetin (Eritropoyetin) Market, Segment by Application
Anemia (Cancer and HIV Treatment)

Kidney Disorders (ESRD and Dialysis)

Others (Neural Disease and Wound Healing)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Epoetin (Eritropoyetin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Epoetin (Eritropoyetin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Epoetin (Eritropoyetin) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Epoetin (Eritropoyetin) Product Introduction
    1.2 Global Epoetin (Eritropoyetin) Market Size Forecast
        1.2.1 Global Epoetin (Eritropoyetin) Sales Value (2019-2030)
        1.2.2 Global Epoetin (Eritropoyetin) Sales Volume (2019-2030)
        1.2.3 Global Epoetin (Eritropoyetin) Sales Price (2019-2030)
    1.3 Epoetin (Eritropoyetin) Market Trends & Drivers
        1.3.1 Epoetin (Eritropoyetin) Industry Trends
        1.3.2 Epoetin (Eritropoyetin) Market Drivers & Opportunity
        1.3.3 Epoetin (Eritropoyetin) Market Challenges
        1.3.4 Epoetin (Eritropoyetin) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Epoetin (Eritropoyetin) Players Revenue Ranking (2023)
    2.2 Global Epoetin (Eritropoyetin) Revenue by Company (2019-2024)
    2.3 Global Epoetin (Eritropoyetin) Players Sales Volume Ranking (2023)
    2.4 Global Epoetin (Eritropoyetin) Sales Volume by Company Players (2019-2024)
    2.5 Global Epoetin (Eritropoyetin) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Epoetin (Eritropoyetin) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Epoetin (Eritropoyetin) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Epoetin (Eritropoyetin)
    2.9 Epoetin (Eritropoyetin) Market Competitive Analysis
        2.9.1 Epoetin (Eritropoyetin) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Epoetin (Eritropoyetin) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epoetin (Eritropoyetin) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Epoetin-alfa
        3.1.2 Epoetin-beta
        3.1.3 Darbepoetin Alfa
    3.2 Global Epoetin (Eritropoyetin) Sales Value by Type
        3.2.1 Global Epoetin (Eritropoyetin) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Epoetin (Eritropoyetin) Sales Value, by Type (2019-2030)
        3.2.3 Global Epoetin (Eritropoyetin) Sales Value, by Type (%) (2019-2030)
    3.3 Global Epoetin (Eritropoyetin) Sales Volume by Type
        3.3.1 Global Epoetin (Eritropoyetin) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Epoetin (Eritropoyetin) Sales Volume, by Type (2019-2030)
        3.3.3 Global Epoetin (Eritropoyetin) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Epoetin (Eritropoyetin) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Anemia (Cancer and HIV Treatment)
        4.1.2 Kidney Disorders (ESRD and Dialysis)
        4.1.3 Others (Neural Disease and Wound Healing)
    4.2 Global Epoetin (Eritropoyetin) Sales Value by Application
        4.2.1 Global Epoetin (Eritropoyetin) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Epoetin (Eritropoyetin) Sales Value, by Application (2019-2030)
        4.2.3 Global Epoetin (Eritropoyetin) Sales Value, by Application (%) (2019-2030)
    4.3 Global Epoetin (Eritropoyetin) Sales Volume by Application
        4.3.1 Global Epoetin (Eritropoyetin) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Epoetin (Eritropoyetin) Sales Volume, by Application (2019-2030)
        4.3.3 Global Epoetin (Eritropoyetin) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Epoetin (Eritropoyetin) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Epoetin (Eritropoyetin) Sales Value by Region
        5.1.1 Global Epoetin (Eritropoyetin) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Epoetin (Eritropoyetin) Sales Value by Region (2019-2024)
        5.1.3 Global Epoetin (Eritropoyetin) Sales Value by Region (2025-2030)
        5.1.4 Global Epoetin (Eritropoyetin) Sales Value by Region (%), (2019-2030)
    5.2 Global Epoetin (Eritropoyetin) Sales Volume by Region
        5.2.1 Global Epoetin (Eritropoyetin) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Epoetin (Eritropoyetin) Sales Volume by Region (2019-2024)
        5.2.3 Global Epoetin (Eritropoyetin) Sales Volume by Region (2025-2030)
        5.2.4 Global Epoetin (Eritropoyetin) Sales Volume by Region (%), (2019-2030)
    5.3 Global Epoetin (Eritropoyetin) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Epoetin (Eritropoyetin) Sales Value, 2019-2030
        5.4.2 North America Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Epoetin (Eritropoyetin) Sales Value, 2019-2030
        5.5.2 Europe Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Epoetin (Eritropoyetin) Sales Value, 2019-2030
        5.6.2 Asia Pacific Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Epoetin (Eritropoyetin) Sales Value, 2019-2030
        5.7.2 South America Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Epoetin (Eritropoyetin) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Epoetin (Eritropoyetin) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Epoetin (Eritropoyetin) Sales Value
        6.2.1 Key Countries/Regions Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Epoetin (Eritropoyetin) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.3.2 United States Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Epoetin (Eritropoyetin) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.4.2 Europe Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Epoetin (Eritropoyetin) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.5.2 China Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Epoetin (Eritropoyetin) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.6.2 Japan Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Epoetin (Eritropoyetin) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.7.2 South Korea Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Epoetin (Eritropoyetin) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.8.2 Southeast Asia Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Epoetin (Eritropoyetin) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Epoetin (Eritropoyetin) Sales Value, 2019-2030
        6.9.2 India Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Epoetin (Eritropoyetin) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Company Information
        7.1.2 Amgen Introduction and Business Overview
        7.1.3 Amgen Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Amgen Epoetin (Eritropoyetin) Product Offerings
        7.1.5 Amgen Recent Development
    7.2 Epoetin
        7.2.1 Epoetin Company Information
        7.2.2 Epoetin Introduction and Business Overview
        7.2.3 Epoetin Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Epoetin Epoetin (Eritropoyetin) Product Offerings
        7.2.5 Epoetin Recent Development
    7.3 Abcam
        7.3.1 Abcam Company Information
        7.3.2 Abcam Introduction and Business Overview
        7.3.3 Abcam Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Abcam Epoetin (Eritropoyetin) Product Offerings
        7.3.5 Abcam Recent Development
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Company Information
        7.4.2 Johnson & Johnson Introduction and Business Overview
        7.4.3 Johnson & Johnson Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Johnson & Johnson Epoetin (Eritropoyetin) Product Offerings
        7.4.5 Johnson & Johnson Recent Development
    7.5 Hospira Inc
        7.5.1 Hospira Inc Company Information
        7.5.2 Hospira Inc Introduction and Business Overview
        7.5.3 Hospira Inc Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Hospira Inc Epoetin (Eritropoyetin) Product Offerings
        7.5.5 Hospira Inc Recent Development
    7.6 Roche
        7.6.1 Roche Company Information
        7.6.2 Roche Introduction and Business Overview
        7.6.3 Roche Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Roche Epoetin (Eritropoyetin) Product Offerings
        7.6.5 Roche Recent Development
    7.7 LG Life Sciences Ltd
        7.7.1 LG Life Sciences Ltd Company Information
        7.7.2 LG Life Sciences Ltd Introduction and Business Overview
        7.7.3 LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Offerings
        7.7.5 LG Life Sciences Ltd Recent Development
    7.8 Biocon
        7.8.1 Biocon Company Information
        7.8.2 Biocon Introduction and Business Overview
        7.8.3 Biocon Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Biocon Epoetin (Eritropoyetin) Product Offerings
        7.8.5 Biocon Recent Development
    7.9 Intas Pharmaceuticals
        7.9.1 Intas Pharmaceuticals Company Information
        7.9.2 Intas Pharmaceuticals Introduction and Business Overview
        7.9.3 Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Offerings
        7.9.5 Intas Pharmaceuticals Recent Development
    7.10 Teva Pharmaceutical Industries Ltd
        7.10.1 Teva Pharmaceutical Industries Ltd Company Information
        7.10.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
        7.10.3 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Offerings
        7.10.5 Teva Pharmaceutical Industries Ltd Recent Development
    7.11 Ranbaxy Laboratories Ltd
        7.11.1 Ranbaxy Laboratories Ltd Company Information
        7.11.2 Ranbaxy Laboratories Ltd Introduction and Business Overview
        7.11.3 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Offerings
        7.11.5 Ranbaxy Laboratories Ltd Recent Development
    7.12 Celltrion, Inc
        7.12.1 Celltrion, Inc Company Information
        7.12.2 Celltrion, Inc Introduction and Business Overview
        7.12.3 Celltrion, Inc Epoetin (Eritropoyetin) Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Celltrion, Inc Epoetin (Eritropoyetin) Product Offerings
        7.12.5 Celltrion, Inc Recent Development

 8 Industry Chain Analysis
    8.1 Epoetin (Eritropoyetin) Industrial Chain
    8.2 Epoetin (Eritropoyetin) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Epoetin (Eritropoyetin) Sales Model
        8.5.2 Sales Channel
        8.5.3 Epoetin (Eritropoyetin) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Epoetin (Eritropoyetin) Market Trends
    Table 2. Epoetin (Eritropoyetin) Market Drivers & Opportunity
    Table 3. Epoetin (Eritropoyetin) Market Challenges
    Table 4. Epoetin (Eritropoyetin) Market Restraints
    Table 5. Global Epoetin (Eritropoyetin) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Epoetin (Eritropoyetin) Revenue Market Share by Company (2019-2024)
    Table 7. Global Epoetin (Eritropoyetin) Sales Volume by Company (2019-2024) & (Units)
    Table 8. Global Epoetin (Eritropoyetin) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Epoetin (Eritropoyetin) Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Epoetin (Eritropoyetin) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Epoetin (Eritropoyetin) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Epoetin (Eritropoyetin)
    Table 13. Global Epoetin (Eritropoyetin) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epoetin (Eritropoyetin) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Epoetin (Eritropoyetin) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Epoetin (Eritropoyetin) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Epoetin (Eritropoyetin) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Epoetin (Eritropoyetin) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Epoetin (Eritropoyetin) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Epoetin (Eritropoyetin) Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
    Table 22. Global Epoetin (Eritropoyetin) Sales Volume by Type (2019-2024) & (Units)
    Table 23. Global Epoetin (Eritropoyetin) Sales Volume by Type (2025-2030) & (Units)
    Table 24. Global Epoetin (Eritropoyetin) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Epoetin (Eritropoyetin) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Epoetin (Eritropoyetin) Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Epoetin (Eritropoyetin) Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Epoetin (Eritropoyetin) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Epoetin (Eritropoyetin) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Epoetin (Eritropoyetin) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Epoetin (Eritropoyetin) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Epoetin (Eritropoyetin) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Epoetin (Eritropoyetin) Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
    Table 34. Global Epoetin (Eritropoyetin) Sales Volume by Application (2019-2024) & (Units)
    Table 35. Global Epoetin (Eritropoyetin) Sales Volume by Application (2025-2030) & (Units)
    Table 36. Global Epoetin (Eritropoyetin) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Epoetin (Eritropoyetin) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Epoetin (Eritropoyetin) Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Epoetin (Eritropoyetin) Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Epoetin (Eritropoyetin) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Epoetin (Eritropoyetin) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Epoetin (Eritropoyetin) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Epoetin (Eritropoyetin) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Epoetin (Eritropoyetin) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Epoetin (Eritropoyetin) Sales Volume by Region (Units): 2019 VS 2023 VS 2030
    Table 46. Global Epoetin (Eritropoyetin) Sales Volume by Region (2019-2024) & (Units)
    Table 47. Global Epoetin (Eritropoyetin) Sales Volume by Region (2025-2030) & (Units)
    Table 48. Global Epoetin (Eritropoyetin) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Epoetin (Eritropoyetin) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Epoetin (Eritropoyetin) Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Epoetin (Eritropoyetin) Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Epoetin (Eritropoyetin) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Epoetin (Eritropoyetin) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Epoetin (Eritropoyetin) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Epoetin (Eritropoyetin) Sales Volume, (2019-2024) & (Units)
    Table 56. Key Countries/Regions Epoetin (Eritropoyetin) Sales Volume, (2025-2030) & (Units)
    Table 57. Amgen Company Information
    Table 58. Amgen Introduction and Business Overview
    Table 59. Amgen Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Amgen Epoetin (Eritropoyetin) Product Offerings
    Table 61. Amgen Recent Development
    Table 62. Epoetin Company Information
    Table 63. Epoetin Introduction and Business Overview
    Table 64. Epoetin Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Epoetin Epoetin (Eritropoyetin) Product Offerings
    Table 66. Epoetin Recent Development
    Table 67. Abcam Company Information
    Table 68. Abcam Introduction and Business Overview
    Table 69. Abcam Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Abcam Epoetin (Eritropoyetin) Product Offerings
    Table 71. Abcam Recent Development
    Table 72. Johnson & Johnson Company Information
    Table 73. Johnson & Johnson Introduction and Business Overview
    Table 74. Johnson & Johnson Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Johnson & Johnson Epoetin (Eritropoyetin) Product Offerings
    Table 76. Johnson & Johnson Recent Development
    Table 77. Hospira Inc Company Information
    Table 78. Hospira Inc Introduction and Business Overview
    Table 79. Hospira Inc Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Hospira Inc Epoetin (Eritropoyetin) Product Offerings
    Table 81. Hospira Inc Recent Development
    Table 82. Roche Company Information
    Table 83. Roche Introduction and Business Overview
    Table 84. Roche Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Roche Epoetin (Eritropoyetin) Product Offerings
    Table 86. Roche Recent Development
    Table 87. LG Life Sciences Ltd Company Information
    Table 88. LG Life Sciences Ltd Introduction and Business Overview
    Table 89. LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Offerings
    Table 91. LG Life Sciences Ltd Recent Development
    Table 92. Biocon Company Information
    Table 93. Biocon Introduction and Business Overview
    Table 94. Biocon Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Biocon Epoetin (Eritropoyetin) Product Offerings
    Table 96. Biocon Recent Development
    Table 97. Intas Pharmaceuticals Company Information
    Table 98. Intas Pharmaceuticals Introduction and Business Overview
    Table 99. Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Offerings
    Table 101. Intas Pharmaceuticals Recent Development
    Table 102. Teva Pharmaceutical Industries Ltd Company Information
    Table 103. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
    Table 104. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Offerings
    Table 106. Teva Pharmaceutical Industries Ltd Recent Development
    Table 107. Ranbaxy Laboratories Ltd Company Information
    Table 108. Ranbaxy Laboratories Ltd Introduction and Business Overview
    Table 109. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Offerings
    Table 111. Ranbaxy Laboratories Ltd Recent Development
    Table 112. Celltrion, Inc Company Information
    Table 113. Celltrion, Inc Introduction and Business Overview
    Table 114. Celltrion, Inc Epoetin (Eritropoyetin) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Celltrion, Inc Epoetin (Eritropoyetin) Product Offerings
    Table 116. Celltrion, Inc Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Epoetin (Eritropoyetin) Downstream Customers
    Table 120. Epoetin (Eritropoyetin) Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Epoetin (Eritropoyetin) Product Picture
    Figure 2. Global Epoetin (Eritropoyetin) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Epoetin (Eritropoyetin) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Epoetin (Eritropoyetin) Sales Volume (2019-2030) & (Units)
    Figure 5. Global Epoetin (Eritropoyetin) Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Epoetin (Eritropoyetin) Report Years Considered
    Figure 7. Global Epoetin (Eritropoyetin) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Epoetin (Eritropoyetin) Players Sales Volume Ranking (2023) & (Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Epoetin (Eritropoyetin) Revenue in 2023
    Figure 10. Epoetin (Eritropoyetin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Epoetin-alfa Picture
    Figure 12. Epoetin-beta Picture
    Figure 13. Darbepoetin Alfa Picture
    Figure 14. Global Epoetin (Eritropoyetin) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Epoetin (Eritropoyetin) Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Epoetin (Eritropoyetin) Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
    Figure 17. Global Epoetin (Eritropoyetin) Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Epoetin (Eritropoyetin) Price by Type (2019-2030) & (USD/Unit)
    Figure 19. Product Picture of Anemia (Cancer and HIV Treatment)
    Figure 20. Product Picture of Kidney Disorders (ESRD and Dialysis)
    Figure 21. Product Picture of Others (Neural Disease and Wound Healing)
    Figure 22. Global Epoetin (Eritropoyetin) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Epoetin (Eritropoyetin) Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Epoetin (Eritropoyetin) Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
    Figure 25. Global Epoetin (Eritropoyetin) Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Epoetin (Eritropoyetin) Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America Epoetin (Eritropoyetin) Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Epoetin (Eritropoyetin) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Epoetin (Eritropoyetin) Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Epoetin (Eritropoyetin) Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Epoetin (Eritropoyetin) Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Epoetin (Eritropoyetin) Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Epoetin (Eritropoyetin) Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Epoetin (Eritropoyetin) Sales Volume (%), (2019-2030)
    Figure 39. United States Epoetin (Eritropoyetin) Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Epoetin (Eritropoyetin) Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Epoetin (Eritropoyetin) Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Epoetin (Eritropoyetin) Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Epoetin (Eritropoyetin) Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Epoetin (Eritropoyetin) Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Epoetin (Eritropoyetin) Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Epoetin (Eritropoyetin) Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Epoetin (Eritropoyetin) Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Epoetin (Eritropoyetin) Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Epoetin (Eritropoyetin) Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Epoetin (Eritropoyetin) Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Epoetin (Eritropoyetin) Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Epoetin (Eritropoyetin) Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Epoetin (Eritropoyetin) Sales Value by Application (%), 2023 VS 2030
    Figure 60. Epoetin (Eritropoyetin) Industrial Chain
    Figure 61. Epoetin (Eritropoyetin) Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

Epoetin can be given intravenously or, more conveniently, subcutaneously, when a 25–50% lower dose can be used.

The global market for Epoetin (Eritropoyetin) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Epoetin (Eritropoyetin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Epoetin (Eritropoyetin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Epoetin (Eritropoyetin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Epoetin (Eritropoyetin) include Amgen, Epoetin, Abcam, Johnson & Johnson, Hospira Inc, Roche, LG Life Sciences Ltd, Biocon and Intas Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Epoetin (Eritropoyetin), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Epoetin (Eritropoyetin) by region & country, by Type, and by Application.

The Epoetin (Eritropoyetin) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epoetin (Eritropoyetin).

Market Segmentation